BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cavalier M, Crouzin N, Ben Sedrine A, de Jesus Ferreira MC, Guiramand J, Cohen-solal C, Fehrentz J, Martinez J, Barbanel G, Vignes M. Involvement of PKA and ERK pathways in ghrelin-induced long-lasting potentiation of excitatory synaptic transmission in the CA1 area of rat hippocampus. Eur J Neurosci 2015;42:2568-76. [DOI: 10.1111/ejn.13013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Sharifi KA, Rezayof A, Alijanpour S, Zarrindast M. GABA-cannabinoid interplays in the dorsal hippocampus and basolateral amygdala mediate morphine-induced amnesia. Brain Research Bulletin 2020;157:61-8. [DOI: 10.1016/j.brainresbull.2020.01.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
2 Khlaifia A, Matias I, Cota D, Tell F. Nutritional status-dependent endocannabinoid signalling regulates the integration of rat visceral information. J Physiol 2017;595:3267-85. [PMID: 28233325 DOI: 10.1113/JP273484] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
3 Lichtstein D, Ilani A, Rosen H, Horesh N, Singh SV, Buzaglo N, Hodes A. Na⁺, K⁺-ATPase Signaling and Bipolar Disorder. Int J Mol Sci 2018;19:E2314. [PMID: 30087257 DOI: 10.3390/ijms19082314] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
4 Li N, Xiao K, Mi X, Li N, Guo L, Wang X, Sun Y, Li GD, Zhou Y. Ghrelin signaling in dCA1 suppresses neuronal excitability and impairs memory acquisition via PI3K/Akt/GSK-3β cascades. Neuropharmacology 2022;203:108871. [PMID: 34742928 DOI: 10.1016/j.neuropharm.2021.108871] [Reference Citation Analysis]
5 Couly S, Paucard A, Bonneaud N, Maurice T, Benigno L, Jourdan C, Cohen-Solal C, Vignes M, Maschat F. Improvement of BDNF signalling by P42 peptide in Huntington's disease. Hum Mol Genet 2018;27:3012-28. [PMID: 29860423 DOI: 10.1093/hmg/ddy207] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
6 Buckinx A, De Bundel D, Kooijman R, Smolders I. Targeting the Ghrelin Receptor as a Novel Therapeutic Option for Epilepsy. Biomedicines 2022;10:53. [DOI: 10.3390/biomedicines10010053] [Reference Citation Analysis]
7 Peng FZ, Fan J, Ge TT, Liu QQ, Li BJ. Rapid anti-depressant-like effects of ketamine and other candidates: Molecular and cellular mechanisms. Cell Prolif 2020;53:e12804. [PMID: 32266752 DOI: 10.1111/cpr.12804] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Palleria C, Leporini C, Maida F, Succurro E, De Sarro G, Arturi F, Russo E. Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes. Frontiers in Neuroendocrinology 2016;42:76-92. [DOI: 10.1016/j.yfrne.2016.07.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
9 Ramirez VT, van Oeffelen WEPA, Torres-Fuentes C, Chruścicka B, Druelle C, Golubeva AV, van de Wouw M, Dinan TG, Cryan JF, Schellekens H. Differential functional selectivity and downstream signaling bias of ghrelin receptor antagonists and inverse agonists. FASEB J 2019;33:518-31. [PMID: 30020830 DOI: 10.1096/fj.201800655R] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
10 Peineau S, Rabiant K, Pierrefiche O, Potier B. Synaptic plasticity modulation by circulating peptides and metaplasticity: Involvement in Alzheimer's disease. Pharmacol Res 2018;130:385-401. [PMID: 29425728 DOI: 10.1016/j.phrs.2018.01.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
11 Yang N, Gabatto P, Bickler PE. Reduction in N-methyl-D-aspartate Receptor-mediated Cell Death in Hippocampal Neurons by Glucose Reduction Preconditioning. J Neurosurg Anesthesiol 2017;29:448-57. [PMID: 28368913 DOI: 10.1097/ANA.0000000000000431] [Reference Citation Analysis]
12 Cornejo MP, Mustafá ER, Barrile F, Cassano D, De Francesco PN, Raingo J, Perello M. THE INTRIGUING LIGAND-DEPENDENT AND LIGAND-INDEPENDENT ACTIONS OF THE GROWTH HORMONE SECRETAGOGUE RECEPTOR ON REWARD-RELATED BEHAVIORS. Neurosci Biobehav Rev 2021;120:401-16. [PMID: 33157147 DOI: 10.1016/j.neubiorev.2020.10.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Nagi K, Habib AM. Biased signaling: A viable strategy to drug ghrelin receptors for the treatment of obesity. Cell Signal 2021;83:109976. [PMID: 33713808 DOI: 10.1016/j.cellsig.2021.109976] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Huang HJ, Chen XR, Han QQ, Wang J, Pilot A, Yu R, Liu Q, Li B, Wu GC, Wang YQ, Yu J. The protective effects of Ghrelin/GHSR on hippocampal neurogenesis in CUMS mice. Neuropharmacology 2019;155:31-43. [PMID: 31103617 DOI: 10.1016/j.neuropharm.2019.05.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]